This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

Scars are a frequent reason of consultation in a dermatological clinic. Their cosmetic aspect can play a key role in patient satisfaction and self-image. Non ablative fractional infra-red laser treatment is a new concept in the laser field using arrays of microscopic thermal damage patterns to stimulate a wound healing response. There are different reports on the positive effect of these type of laser treatment in the treatment of acne scarring, striae, rythides, hypopigmented and hypertrophic scars. The low morbidity of the treatment and the lack of satisfying treatment regimes for different types of scars makes it attractive to investigate the efficacy and safety of 4 treatment with the 1540nm non ablative fractional laser in the treatment of scars. Objectives: - To evaluate the efficacy of 4 laser treatments with Starlux 300 Lux 1540nm Fractional laser handpiece ( Palomar Medical Technologies ) 1 and 3 month after the last laser treatment for 3 different "scar" patient groups : 1. Patients with hypopigmented scars 2. Patients with hypertrophic scars 3. Patients with scars due to grafts and reconstructions in the head and neck region. - To evaluate the treatment related pain. on a categorical scale from 0-10 - To evaluate the adverse effect of 1540nm fractional laser versus untreated control in the 3 patient groups. The study design is a prospective single blinded randomised within-patient controlled study The study involves 6 visits.

Provided treatments

  • Procedure: laser treatment
  • Procedure: treatment without laser
  • Procedure: laser treatment

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01056211. The sponsor of the trial is University Hospital, Ghent and it is looking for 90 volunteers for the current phase.
Official trial title:
1540nm Non Ablative Fractional Laser Treatment of Scars : a Prospective Single Blinded Within Patient Controlled Randomized Trial.